Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Stahmann

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
The Lancet Regional Health. Europe|September 12, 2022
SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational studyNiklas Frahm, Firas Fneish, David Ellenberger, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2024
Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS RegistryNiklas Frahm, David Ellenberger, Alexander Stahmann, et al.
Contemporary Clinical Trials Communications|June 2, 2020
Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot studyAhmed Abdelhak, Andre Huss, Alexander Stahmann, et al.
Plos One|November 11, 2021
How is and how should healthcare for people with multiple sclerosis in Germany be designed?-The rationale and protocol for the mixed-methods study Multiple Sclerosis-Patient-Oriented Care in Lower Saxony (MS-PoV)Kathrin Krüger, Lara Marleen Fricke, Elise-Marie Dilger, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 24, 2024
Subgroup analyses and patterns of multiple sclerosis health service utilisation: A cluster analysisLara Marleen Fricke, Kathrin Krüger, Corinna Trebst, et al.
Annals of Clinical and Translational Neurology|December 19, 2023
Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.
Multiple Sclerosis and Related Disorders|December 5, 2020
Multiple Sclerosis Data Alliance - A global multi-stakeholder collaboration to scale-up real world data researchLiesbet M Peeters, Tina Parciak, Dipak Kalra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 23, 2023
Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task forceTina Parciak, Lotte Geys, Anne Helme, et al.
Therapeutic Advances in Neurological Disorders|September 29, 2023
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across EuropeRichard Nicholas, Jeff Rodgers, James Witts, et al.
BMJ Open|January 26, 2022
Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocolHeidrun Golla, Kim Dillen, Martin Hellmich, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Lancet Regional Health. Europe|September 12, 2022
SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational studyNiklas Frahm, Firas Fneish, David Ellenberger, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2024
Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS RegistryNiklas Frahm, David Ellenberger, Alexander Stahmann, et al.
Contemporary Clinical Trials Communications|June 2, 2020
Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot studyAhmed Abdelhak, Andre Huss, Alexander Stahmann, et al.
Plos One|November 11, 2021
How is and how should healthcare for people with multiple sclerosis in Germany be designed?-The rationale and protocol for the mixed-methods study Multiple Sclerosis-Patient-Oriented Care in Lower Saxony (MS-PoV)Kathrin Krüger, Lara Marleen Fricke, Elise-Marie Dilger, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 24, 2024
Subgroup analyses and patterns of multiple sclerosis health service utilisation: A cluster analysisLara Marleen Fricke, Kathrin Krüger, Corinna Trebst, et al.
Annals of Clinical and Translational Neurology|December 19, 2023
Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.
Multiple Sclerosis and Related Disorders|December 5, 2020
Multiple Sclerosis Data Alliance - A global multi-stakeholder collaboration to scale-up real world data researchLiesbet M Peeters, Tina Parciak, Dipak Kalra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 23, 2023
Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task forceTina Parciak, Lotte Geys, Anne Helme, et al.
Therapeutic Advances in Neurological Disorders|September 29, 2023
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across EuropeRichard Nicholas, Jeff Rodgers, James Witts, et al.
BMJ Open|January 26, 2022
Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocolHeidrun Golla, Kim Dillen, Martin Hellmich, et al.
Pageof 5